ALDX
Aldeyra The
NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY
$1.52
+1.33% today
Updated 2026-04-30
Market cap
$90.48M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.56
Dividend yield
—
52W range
$1 – $6
Volume
3.6M
Aldeyra The (ALDX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+52.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-16.5%
2026-03-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $-0.11 | +29.0% | $4.94 | $4.13 | -16.5% |
| 2025-11-05 | $-0.13 | +46.9% | $4.92 | $4.81 | -2.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.09 | $0.00 | +100.0% | — | — |
| 2025-12-31 | $-0.16 | $-0.11 | +29.0% | — | — |
| 2025-09-30 | $-0.25 | $-0.13 | +46.9% | — | — |
| 2025-06-30 | $-0.24 | $-0.16 | +34.2% | — | — |
| 2025-03-31 | $-0.24 | $-0.17 | +30.3% | — | — |
| 2024-12-31 | $-0.22 | $-0.27 | -24.3% | $244526.00 | -37.7% |
| 2024-09-30 | $-0.25 | $-0.25 | +0.0% | — | — |
| 2024-06-30 | $-0.14 | $-0.28 | -100.0% | — | — |
| 2024-03-31 | $-0.11 | $-0.14 | -27.3% | — | — |
| 2023-12-31 | $-0.14 | $-0.08 | +42.9% | $392620.00 | — |
| 2023-09-30 | $-0.24 | $-0.14 | +41.7% | — | — |
| 2023-06-30 | $-0.31 | $-0.15 | +51.6% | — | — |
Frequently asked questions
Has Aldeyra The beaten earnings estimates?
Aldeyra The has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +52.6% over the last 4 quarters.
How does ALDX stock react to earnings?
ALDX stock has moved an average of -9.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.